Bausch Health Companies (BHC) Long-Term Deferred Tax (2009 - 2026)

Bausch Health Companies has disclosed Long-Term Deferred Tax across 18 years of filings, most recently posting $1.8 billion for Q2 2026.

• In Q2 2026, Long-Term Deferred Tax fell 8.89% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $1.8 billion (down 8.89% YoY), while the FY2025 annual figure was $1.8 billion, down 6.35% from the prior year.
• Long-Term Deferred Tax came in at $1.8 billion for Q2 2026 at Bausch Health Companies, roughly flat from $1.8 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.4 billion in Q3 2022 to a low of $1.8 billion in Q4 2025.
• Average Long-Term Deferred Tax over 5 years is $2.1 billion, with a median of $2.2 billion recorded in 2023.
• Year-over-year, Long-Term Deferred Tax grew 6.14% in 2022 and decreased 8.89% in 2026.
• Over 5 years, Long-Term Deferred Tax stood at $2.2 billion in 2022, then retreated by 3.0% to $2.1 billion in 2023, then fell by 6.33% to $2.0 billion in 2024, then dropped by 6.35% to $1.8 billion in 2025, then gained by 0.11% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $1.8 billion in Q2 2026, $1.8 billion in Q1 2026, and $1.8 billion in Q4 2025.